Recovery of smell sense loss by mepolizumab in a patient allergic to Dermatophagoides and affected by chronic rhinosinusitis with nasal polyps.
Carlo CavaliereCristoforo IncorvaiaFranco FratiDaniela MessineoMario CiottiAntonio GrecoMarco de VincentiisSimonetta MasieriPublished in: Clinical and molecular allergy : CMA (2019)
In this case report, the treatment with mepolizumab in a patient allergic to Dermatophagoides and affected by CRSwNP was associated with an improvement of anosmia. That finding may be explained by a reduction of the nasal obstruction by nasal polyps.